DVA

DAVITA INC

Apr 05 • 04:00PM ET

145.41

+1.81 (+1.26%)

Company Profile

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease m ... read more

Full Time Employees 70,000

Phone 720 631 2100

Website https://www.davita.com

CEO Mr. Javier J. Rodriguez

IPO Date 1995-10-31

Sector Healthcare

Industry Medical - Care Facilities

Address 2000 16th Street, Denver, CO 80202

Balance Sheet

Total Cash $524,573,000

Total Debt $12,320,338,000

Current Ratio 1.25

Quick Ratio 1.15

Profitability

Gross Margin 32.46%

Net Margin 6.63%

ROE -321.83%

ROA 5.02%

ROIC 12.78%

Balance Sheet

Total Cash $524,573,000

Total Debt $12,320,338,000

Current Ratio 1.25

Quick Ratio 1.15

Profitability

Gross Margin 32.46%

Net Margin 6.63%

ROE -321.83%

ROA 5.02%

ROIC 12.78%

Name	DAVITA INC	Sector	Healthcare	Currency	USD	Relative Volume	1.13	Market Cap	11959
Current Ratio	1.26	Dividend / Share	0.0	EPS	10.73	Revenue	12815550000	P/S	0.9
P/E	12.8	Beta	0.43	Income	936342000	Volume	1009307	Average Volume	892704
Distance to 200DMA	-2.48%	200 DMA	153.29	50 DMA	156.02	ROA	5.4	ROE	181.2
Distance to 50DMA	-4.19%	Return 1Y	10.5%	Return YTD	-0.04%	Forward PE		Qtly Growth YOY
Debt/Eq	125.44	P/B	98.7	Dividend Yield	0.0%	Net Margin	7.31%	Payout Ratio	0.0

Performance

52 Week Range 0.0%

Distance to 200DMA 0.0%

Day Change Percent $0.00

Performance Range

Day

$196

Current

Low: High:

Month

$196

Current

Low: High:

Month

$196

Current

Low: High:

Month

$196

Current

Low: High:

Month

$196

Current

Low: High:

Balance Sheet

Total Cash $1,158,644,000

Total Debt $12,198,261,000

Current Ratio 1.37%

Quick Ratio 1.29%

Profitability

Valuation

Price to Earnings 13.43

Price to Book -43.21

Price to Sales 0.89

Price to Free Cash Flow 6.56

Dividends

Payout Ratio 0.00%

Dividend Yield 0.00%

Dividend Amount $0.00

Performance

52 Week Range 0.0%

Distance to 200DMA 0.0%

Day Change Percent $0.00

Company Profile

Full Time Employees 70,000

Phone 720 631 2100

Website https://www.davita.com

CEO Mr. Javier J. Rodriguez

IPO Date 1995-10-31

Sector Healthcare

Address 2000 16th Street, Denver, CO 80202

Histogram - Daily

Balance Sheet

Total Cash $1,158,644,000

Total Debt $12,198,261,000

Current Ratio 1.37%

Quick Ratio 1.29%

Profitability

Gross Margin 0.3280%

Net Margin 0.0650%

ROE 1.10%

ROA 0.05%

Company Profile

Full Time Employees 70,000

Phone 720 631 2100

Website https://www.davita.com

CEO Mr. Javier J. Rodriguez

IPO Date 1995-10-31

Sector Healthcare

Address 2000 16th Street, Denver, CO 80202

Monthly Win Rate

Balance Sheet (Multi-Column Example)

	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023
Cash & Short Term Investments	53,775.0	65,171.0	61,801.0	67,150.0	73,100.0	61,555.0	62,482.0	55,872.0
Receivables	59,306.0	66,243.0	43,172.0	41,150.0	50,102.0	60,985.0	39,186.0	35,899.0
Inventory	6,911.0	7,286.0	6,165.0	6,232.0	6,511.0	6,331.0	7,351.0	7,482.0

Latest News

Here's Why DaVita HealthCare (DVA) is a Strong Growth Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

2025-05-15 10:50:30 - zacks.com

Why DaVita HealthCare (DVA) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

2025-05-14 10:41:04 - zacks.com

DaVita Stock Down Despite Q1 Earnings Beat, Margins Contract

Strength in revenue per treatment and dialysis patient service revenues drives DVA's first-quarter 2025 performance despite a year-over-year decline in normalized non-acquired treatment.

2025-05-13 13:15:39 - zacks.com

DaVita HealthCare (DVA) Q1 Earnings and Revenues Beat Estimates

DaVita HealthCare (DVA) came out with quarterly earnings of $2 per share, beating the Zacks Consensus Estimate of $1.75 per share. This compares to earnings of $2.38 per share a year ago.

2025-05-12 18:20:54 - zacks.com

DaVita beats quarterly profit estimates amid stable demand for dialysis services

DaVita beat Wall Street estimates for first-quarter profit on Monday, driven by steady demand for its kidney dialysis services.

2025-05-12 17:37:59 - reuters.com

DaVita First-Quarter 2025 Financial Results: Just the Numbers

Kidney treatment company DaVita (DVA) on Monday afternoon reported first-quarter 2025 financial results. A summary of its key numbers is below.

2025-05-12 16:51:08 - investopedia.com

DaVita Inc. 1st Quarter 2025 Results

DENVER , May 12, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended March 31, 2025. "Our strong first quarter performance demonstrates the sta

2025-05-12 16:05:00 - prnewswire.com

Can Revenue Cycle Operations Drive DVA Stock Before Q1 Earnings?

Continued strength in revenue cycle operations is likely to have boosted DaVita's top line in the first quarter despite supply challenges weighing on its performance.

2025-05-08 12:55:31 - zacks.com

DaVita HealthCare (DVA) Outperforms Broader Market: What You Need to Know

DaVita HealthCare (DVA) closed the most recent trading day at $143.96, moving +0.94% from the previous trading session.

2025-05-07 19:00:39 - zacks.com

DaVita HealthCare (DVA) Stock Falls Amid Market Uptick: What Investors Need to K

DaVita HealthCare (DVA) closed at $140.44 in the latest trading session, marking a -0.78% move from the prior day.

2025-05-01 19:06:31 - zacks.com

DaVita Inc. Schedules 1st Quarter 2025 Investor Conference Call

DENVER , April 30, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss first quarter results on Monday, May 12, 2025, at 5:00 p.m.

2025-04-30 11:00:00 - prnewswire.com

DaVita HealthCare (DVA) Ascends But Remains Behind Market: Some Facts to Note

In the latest trading session, DaVita HealthCare (DVA) closed at $134.97, marking a +1.1% move from the previous day.

2025-04-22 19:05:33 - zacks.com

3 No-Brainer Warren Buffett Stocks to Buy Right Now

In uncertain markets, it pays to follow proven wisdom -- and few investors have a track record as legendary as Warren Buffett. Since taking over Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) in 1965,

2025-04-19 04:30:00 - fool.com

Why DaVita Stock Got Rocked This Week

We're in an age when the threat of cyberattacks is real and substantial. Confirming this, veteran healthcare company DaVita (DVA -0.91%) suffered a hacker ambush in recent days, a situation that spook

2025-04-18 18:13:28 - fool.com

DaVita HealthCare (DVA) Stock Declines While Market Improves: Some Information f

DaVita HealthCare (DVA) concluded the recent trading session at $140.03, signifying a -1.04% move from its prior day's close.

2025-04-17 19:20:29 - zacks.com

DaVita Says Ransomware Attack Affecting Some Operations

DaVita has been hit with a ransomware attack that has affected some of the kidney-care company's operations.

2025-04-14 07:35:00 - wsj.com